Lesson plan

PolyIran

The PolyIran study is a pragmatic open-labeled randomized trial that was conducted within Golestan cohort study (GCS) on 31000 subjects in 305 villages of Golestan Province, northeastern Iran. The pill used in this study, "Polypill", has been successfully evaluated in a pilot study and consists of 4 components. It is estimated to decrease the death rate due to myocardial infarction and stroke by 30-53%. Participants were enrolled in the study during February 2011 and April 2013. The study directly evaluates the effect of Polypill tablets on cardiovascular death and hospitalizations compared to lifestyle modification during 5 years of follow-up; unlike most of the studies that only investigate the impact of Polypill on indirect surrogate markers of cardiovascular diseases such as blood pressure or lipid profile. The study includes three arms. The first and largest arm (24000 subjects) were just followed and received no particular care other than care provided by the governmental health system in Iran (usual care arm). The second arm (3500 subjects) received recommendations about a healthy lifestyle in face-to-face interviews and pamphlets, underwent blood pressure measurements in 6 months regular intervals, and were referred to secondary or tertiary medical centers for treatment upon necessity (minimal care arm).…

Back to article

Article summary

The PolyIran study is a pragmatic open-labeled randomized trial that was conducted within Golestan cohort study (GCS) on 31000 subjects in 305 villages of Golestan Province, northeastern Iran. The pill used in this study, "Polypill", has been successfully evaluated in a pilot study and consists of 4 components. It is estimated to decrease the death rate due to myocardial infarction and stroke by 30-53%. Participants were enrolled in the study during February 2011 and April 2013. The study directly evaluates the effect of Polypill tablets on cardiovascular death and hospitalizations compared to lifestyle modification during 5 years of follow-up; unlike most of the studies that only investigate the impact of Polypill on indirect surrogate markers of cardiovascular diseases such as blood pressure or lipid profile. The study includes three arms. The first and largest arm (24000 subjects) were just followed and received no particular care other than care provided by the governmental health system in Iran (usual care arm). The second arm (3500 subjects) received recommendations about a healthy lifestyle in face-to-face interviews and pamphlets, underwent blood pressure measurements in 6 months regular intervals, and were referred to secondary or tertiary medical centers for treatment upon necessity (minimal care arm).…

Key claims

No claims recorded.

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  3. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.